Agostina Nardone

机构：Harvard University, Dana-Farber Cancer Institute, AstraZeneca (Spain), Hospital of Prato · ORCID：0000-0003-3277-1101

发表论文 332 篇 · 总被引 2153 次 · h-index 21

代表论文

• Abstract RF7-05: Capivasertib plus fulvestrant in hormone receptor-positive (HR+) advanced breast cancer (ABC): exploratory ctDNA analyses from the Phase 3 CAPItello-291 trial (2026 · Clinical Cancer Research · 被引 5)
• ctDNA Detection with Low-Pass Whole-Genome Bisulfite Sequencing in RAS Wild-Type Metastatic Colorectal Cancer: An Exploratory Objective of the VALENTINO Trial (2025 · Clinical Cancer Research · 被引 2)
• ESR1 mutations and CDK4/6 inhibitor choice shape clonal selection and adaptive cell states during acquired resistance (2026 · Genome Medicine · 被引 1)
• A computational framework for sensitive tumor detection and accurate subtyping using shallow cell-free DNA methylome sequencing (2026 · Genome Medicine · 被引 1)
• Supplementary Data1 from Exploratory Analysis of PTEN Deficiency by Immunohistochemistry from the Phase III CAPItello-291 Trial (2026)
• Data from Exploratory Analysis of PTEN Deficiency by Immunohistochemistry from the Phase III CAPItello-291 Trial (2026)